Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns naming Maeve von Heynitz .
Filed returns
69
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| May–Aug 2026 | Eli Lilly and Company | Economic Development and Industry | EU and Irish life sciences policy development and competitiveness (Public policy or programme) | 9 | On lobbying.ie |
| May–Aug 2026 | Google Ireland Limited | Economic Development and Industry | EU Digital Legislation (Legislation) | 7 | On lobbying.ie |
| May–Aug 2026 | Amgen | EU Affairs | Participation in a multi stakeholder life sciences roundtable on EU and Irish policy issues affecting the sector's competitiveness (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2026 | Hume Brophy | Trade | Bayer asked for and conducted meetings with relevant officials to discuss matters about the European pharmaceutical industry, particularly on the US 301 investigation. (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2026 | Meta Platforms Ireland Ltd | EU Affairs | Encouraging Ireland to prioritise competitiveness and innovation during its Presidency of the Council of the European Union. (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2026 | Bayer Limited | EU Affairs | Updating of uSPC policy (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2026 | Bayer Limited | Trade | USTR S301 Investigation, the pharmaceutical sector trade environment and the Food and Feed Safety Omnibus (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2026 | Pfizer | Health | Discussion on the EU Biotech Act, access to medicines, innovation, and Ireland's life sciences policy environment, including opportunities to strengthen research, development, manufacturing, and the competitiveness of… (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2026 | Irish Funds Industry Association CLG | EU Affairs | Domestic & EU Legislative Agenda (Public policy or programme) | 60 | On lobbying.ie |
| May–Aug 2026 | Hanover Media Strategy Limited | Finance | Changes to the de minimis regime for low value imports. (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2026 | MSD | Health | Discussion on EU pharmaceutical policy during Irish EU Presidency (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2026 | Ibec | Environment | Single Use Plastics Directive: Implementing Decision on recycled plastic content in single-use beverage bottles (Legislation) | 4 | On lobbying.ie |
| Jan–Apr 2026 | Google Ireland Limited | Economic Development and Industry | EU Digital Simplification Package (Legislation) | 8 | On lobbying.ie |
| Jan–Apr 2026 | Google Ireland Limited | Economic Development and Industry | EU’s proposed AI Omnibus Regulation (Legislation) | 8 | On lobbying.ie |
| Jan–Apr 2026 | Janssen Sciences Ireland UC | Health | Meetings with Government Ministers, parliamentarians, and officials with the US Chamber of Commerce delegation in February 2026 (Public policy or programme) | 7 | On lobbying.ie |
| Jan–Apr 2026 | American Chamber of Commerce Ireland | EU Affairs | EU Presidency discussions (Public policy or programme) | 7 | On lobbying.ie |
| Jan–Apr 2026 | Ibec | Economic Development and Industry | Global Trade Forum 2nd March (Public policy or programme) | 15 | On lobbying.ie |
| Jan–Apr 2026 | Ibec | Economic Development and Industry | Meeting with Minister McEntee on 16th April in the Ibec Office (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2026 | DOCHAS - THE IRISH ASSOCIATION OF NON- GOVERNMENTAL DEVELOPMENT ORGANISATIONS | Foreign Affairs | Policy Brief on the Global Europe Instrument (GEI) and negotiations on the Multiannual Financial Framework (Matters involving public funds) | 3 | On lobbying.ie |
| Jan–Apr 2026 | Irish Distillers | Economic Development and Industry | To engage with relevant stakeholders regarding US tariffs on Irish whiskey (Public policy or programme) | 7 | On lobbying.ie |
| Jan–Apr 2026 | Sanofi | Health | enhanced vaccines for influenza public health strategies (Public policy or programme) | 15 | On lobbying.ie |
| Jan–Apr 2026 | Pinnacle Public Affairs Ltd | Economic Development and Industry | To engage with Key Stakeholders regarding proposed EU-US Trade Tariffs (Public policy or programme) | 7 | On lobbying.ie |
| Jan–Apr 2026 | AerCap Holdings N.V. | Foreign Affairs | General exchange on aviation leasing industry and policy developments including taxation, tariffs/trade. (Public policy or programme) | 6 | On lobbying.ie |
| Jan–Apr 2026 | Ibec | Finance | EU/US tariff deal (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2026 | Ibec | Trade | Ibec submission to United States Trade Representative (USTR) concerning Section 301 Investigation (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2026 | Ibec | EU Affairs | Meeting to discuss Ibec's Trade Policy Priorities for the Irish Presidency of the EU (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2026 | Ibec | Environment | Single Use Plastics Directive: Implementing Decision on recycled plastic content in single-use beverage bottles (Legislation) | 4 | On lobbying.ie |
| Jan–Apr 2026 | Chambers Ireland | Trade | Renewed call for Irish Government support for Mercosur in light of recent European Council and European Parliamnet votes against (Public policy or programme) | 10 | On lobbying.ie |
| Jan–Apr 2026 | Chambers Ireland | EU Affairs | Key recommendations in relation to addressing impact of trade policy uncertainty on investment (Public policy or programme) | 10 | On lobbying.ie |
| Jan–Apr 2026 | Chambers Ireland | Trade | Key recommendations in relation to addressing impact of trade policy uncertainty on investment (Public policy or programme) | 10 | On lobbying.ie |
| Jan–Apr 2026 | Amazon Ireland Support Services Limited | Economic Development and Industry | To discuss Ireland's priorities for the Presidency of the Council of the EU. (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2025 | Janssen Sciences Ireland UC | EU Affairs | Meeting with Maeve von Heynitz (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2025 | Ibec | EU Affairs | EU Presidency campaign report (Public policy or programme) | 9 | On lobbying.ie |
| Sep–Dec 2025 | Ibec | EU Affairs | Single market priorities for EU Presidency (Public policy or programme) | 6 | On lobbying.ie |
| Sep–Dec 2025 | SSLF Progress Ireland | EU Affairs | Discussion of EU environmental directives (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2025 | Ibec | EU Affairs | Trade and investment priorities for EU Presidency (Public policy or programme) | 7 | On lobbying.ie |
| Sep–Dec 2025 | Ibec | EU Affairs | Enterprise and Economy priorities for EU Presidency (Public policy or programme) | 13 | On lobbying.ie |
| Sep–Dec 2025 | Ibec | EU Affairs | Digital and AI policy priorities for EU Presidency (Public policy or programme) | 8 | On lobbying.ie |
| Sep–Dec 2025 | AerCap Holdings N.V. | Foreign Affairs | General exchange on policy developments including taxation, tariffs/trade. (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2025 | Intel Ireland Limited | Economic Development and Industry | to learn about plans for government events during the upcoming Presidency of the EU Council (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2025 | Ibec | Economic Development and Industry | BioPharmaChem Impact 2026 (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2025 | Ibec | Trade | Engagement on Ibec's Trade Policy priorities paper for Irish Presidency of the EU (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2025 | MSD | EU Affairs | EU Pharma Task Force (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2025 | Bayer Limited | EU Affairs | IPHA Delegation to discuss Ireland's upcoming EU Council Presidency (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2025 | Bayer Limited | EU Affairs | IPHA Delegation to meet with An Tánaiste on EU health legislation and policy matters (including GPL and Ireland's EU Presidency), as well as the domestic issue of the negotiation of the pricing and supply agreement. (Legislation) | 7 | On lobbying.ie |
| May–Aug 2025 | Google Ireland Limited | Economic Development and Industry | Responsible use and regulation of AI (Public policy or programme) | 8 | On lobbying.ie |
| May–Aug 2025 | Irish Pharmaceutical Healthcare Association | Health | Future Framework Agreement - issues concerning timely reimbursement of medicines in Ireland. (Legislation) | 10 | On lobbying.ie |
| May–Aug 2025 | Irish Pharmaceutical Healthcare Association | Health | US Tariffs and EU - Irish Response (Matters involving public funds) | 8 | On lobbying.ie |
| May–Aug 2025 | Irish Pharmaceutical Healthcare Association | Health | (i) EU General Pharmaceutical Legislation and Irish Government position on Intellectual Property Rights. (ii) EU and Irish competitiveness and the pharmaceutical industry. (Legislation) | 6 | On lobbying.ie |
| May–Aug 2025 | Irish Pharmaceutical Healthcare Association | Health | US Tariffs and EU - Irish Response (Public policy or programme) | 8 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| EU Affairs | 22 | 31.9% | |
| Economic Development and Industry | 16 | 23.2% | |
| Trade | 12 | 17.4% | |
| Health | 9 | 13.0% | |
| Foreign Affairs | 6 | 8.7% | |
| Environment | 2 | 2.9% | |
| Finance | 2 | 2.9% |